ArticlePloS one2025
Cytomegalovirus host receptor expression in the human fetal inner ear.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fetal infection with human cytomegalovirus (hCMV) can cause sensorineural hearing loss and vestibular impairment, yet its pathogenesis remains unclear. This study aims to identify potential target cell types of hCMV in the human fetal inner ear. Viral particles use several envelope glycoproteins to enter target cells, including the pentameric complex, the trimeric complex and glycoprotein B. Platelet-derived growth factor receptor alpha (PDGFRA) serves as the receptor in fibroblasts, neuropilin-2 (NRP2) in epithelial, endothelial and dendritic cells as well as in leukocytes. Upon binding of these glycoproteins, glycoprotein B initiates membrane fusion which is proposed to be mediated by EGFR. When and where these proteins are expressed in the fetal inner ear during development is unknown. To address this, expression patterns of PDGFRA, NRP2 and EGFR were investigated in human fetal inner ear tissue using single-nucleus RNA sequencing data (first trimester: N = 2) and immunohistochemistry (first trimester: N = 6, second trimester: N = 5). PDGFRA gene and protein expression was detected in mesenchymal cells, NRP2 protein expression in epithelial cells and endothelial cells, and EGFR gene and protein expression in both epithelial cells and mesenchymal cells. Notably, all three receptors were present in tissue from the first and second trimesters. In conclusion, hCMV host receptors PDGFRA, NRP2 and EGFR are expressed in mesenchymal, epithelial and endothelial cells within the cochlea and vestibular organs during the first and second trimesters. These cell types may serve as targets for hCMV infection of the fetal inner ear.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.